Bartels C. F., Jensen F. S., Lockridge O., van der Spek A. F., Rubinstein H. M., Lubrano T., and La Du B. N. (1992) DNA mutation associated with the human butyryl-cholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet.
50, 1086–1103.
PubMed
CAS
Google Scholar
Kalow W. and Gunn D. R. (1957) The relation of between dose of succinylcholine and duration of apnea in man. J. Pharmacol. Exp. Ther.
120, 203–214.
PubMed
CAS
Google Scholar
Kalow, W. and Gunn, D. R. (1959). Some statistical data on atypical cholinesterase of human serum. Ann. Hum. Genet.
23, 239–250.
PubMed
CAS
Google Scholar
Liu P., Jenkins N. A., and Copeland N. G. (2003) A highly effencient recombineering-based method for generating conditional knockout mutations. Genome Res.
13, 476–484.
PubMed
Article
CAS
Google Scholar
Lockridge O. (1990) Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol. Ther.
47, 35–60.
PubMed
Article
CAS
Google Scholar
McGuire M. C., Nogueira C. P., Bartels C. F., Lightstone H., Hajra A., Van der Spek A. F., et al. (1989) Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. Proc. Natl. Acad. Sci. U.S.A.
86, 953–957.
PubMed
Article
CAS
Google Scholar